Biomedical Engineering Reference
In-Depth Information
Tsutamoto, T. and A. Wada, K. Maeda, N. Mabuchi, M. Hayashi, T. Tsutsui, M. Ohnishi, M.
Sawaki, M. Fujii, T. Matsumoto, and M. Kinoshita. 2000. Angiotensin II type 1 receptor
antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and
soluble adhesion molecules in patients with chronic heart failure. J Am. Coll. Cardiol.
35: 714-721.
Wolf, P.A. and R.D. Abbott, and W.B. Kannel. 1991. Atrial i brillation as an independent
risk factor for stroke: the Framingham Study. Stroke 22: 983-988.
